James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $565.85 ($5.7M) on 2026-04-27, disclosed to the SEC on 2026-04-28.
Scheduled sale ($5.7M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $565.85 | 1,716 | $971K | 17.1% |
| 2 | $566.73 | 1,449 | $821K | 14.4% |
| 3 | $567.81 | 919 | $522K | 9.2% |
| 4 | $569.01 | 1,107 | $630K | 11.1% |
| 5 | $570.05 | 2,405 | $1.4M | 24.1% |
| 6 | $571.10 | 1,755 |
| $1.0M |
| 17.6% |
| 7 | $571.92 | 649 | $371K | 6.5% |
| Total | $568.83 avg | 10,000 | $5.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |